| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/30/2014 | US20140031353 Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof |
| 01/30/2014 | US20140031350 2,4-Pyrimidinediamine Compounds and Their Uses |
| 01/30/2014 | US20140031345 Quinazolines as potassium ion channel inhibitors |
| 01/30/2014 | US20140031339 Inhibitors of leukotriene production |
| 01/30/2014 | US20140031336 Tetrahydroquinoline Derivatives Useful As Bromodomain Inhibitors |
| 01/30/2014 | US20140031331 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 01/30/2014 | US20140031329 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases |
| 01/30/2014 | US20140030243 Anthranilamides compositions |
| 01/30/2014 | CA2876391A1 4-[5-(pyridine-4-yl)-1h-1,2,4-triazole-3-yl]pyridine-2-carbonitrile crystalline polymorph and production method therefor |
| 01/30/2014 | CA2876268A1 Method for producing 4-[5-(pyridin-4-yl)-1h-1,2,4-triazole-3-yl]pyridine-2-carbonitrile, and intermediate thereof |
| 01/29/2014 | EP2690091A1 Process for preparing substituted indole derivatives |
| 01/29/2014 | EP2688880A1 Grafted dinuclear metal complexes, and use thereof as cellular microparticle sensors |
| 01/29/2014 | EP2688870A1 Heterocyclic amine derivatives |
| 01/29/2014 | EP2688649A1 Polymorphs of lenalidomide |
| 01/29/2014 | EP2418202B1 (4-[4-[5-(substituted amino)-pyridin-2-yl]phenyl]-cyclohexyl)-acetic acid derivatives as DGAT inhibitors |
| 01/29/2014 | EP2394999B1 Aminopyrazine derivative and medicine |
| 01/29/2014 | EP2078010B1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/29/2014 | EP1790637B1 Derivatives of N-4-piperidyl urea and medicaments containing them as active ingredient |
| 01/29/2014 | CN1914224B HCV NS-3 serine protease inhibitors |
| 01/29/2014 | CN103547575A Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
| 01/29/2014 | CN103547566A Aminoindane compounds and use thereof in treating pain |
| 01/29/2014 | CN103539785A 大麻素受体调节剂 Cannabinoid receptor modulators |
| 01/29/2014 | CN103539783A I-type crystal of dimaleate of tyrosine kinase inhibitor and preparation method thereof |
| 01/29/2014 | CN103539782A Disesquihydrate of esomeprazole magnesium salt and preparation method of disesquihydrate |
| 01/29/2014 | CN103539781A Method for synthesizing WNT (Wingless Int.) signal path inhibitor |
| 01/29/2014 | CN103539780A Substituted pyrazolone compounds as well as use method and application of substituted pyrazolone compounds |
| 01/29/2014 | CN103539779A Hydroxyl substituted benzene sulfonate of dabigatran etexilate and preparation method and usage thereof |
| 01/29/2014 | CN103539778A Pyridine-pyrazole heterocyclic dihydrazide derivatives as well as preparation method and application thereof |
| 01/29/2014 | CN103539777A PI3 kinase regulator as well as use method and application of PI3 kinase regulator |
| 01/29/2014 | CN103539776A Novel sitafloxacin crystal form and preparation method thereof |
| 01/29/2014 | CN103539775A Dipyridine bridged bis-triazine compounds and preparation method thereof |
| 01/29/2014 | CN103539737A Aza-phenanthro-fluorene derivative and preparation method thereof as well as electrically-induced fluorescence luminescent device |
| 01/29/2014 | CN103539726A Novel compound with electron injection and/or electron transport capabilities and organic light-emitting device including the same |
| 01/29/2014 | CN102675101B Preparation method of 2-(4-haloethyl) phenyl-2-methyl propionic ester and synthesis method of bilastine |
| 01/29/2014 | CN102348702B Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof |
| 01/29/2014 | CN101801958B Heterocyclic amide compounds as protein kinase inhibitors |
| 01/29/2014 | CN101679355B Benzimidazole cannabinoid agonists |
| 01/29/2014 | CN101501007B Quinazoline derivative |
| 01/29/2014 | CN101495458B Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptors |
| 01/28/2014 | US8637681 Pyrrolyl substituted dihydroindol-2-one derivatives, preparation methods and uses thereof |
| 01/28/2014 | US8637672 Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities |
| 01/28/2014 | US8637548 Therapeutic agents useful for treating pain |
| 01/28/2014 | US8637546 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DDP-IV) |
| 01/28/2014 | US8637534 Fungicide active substance combinations |
| 01/28/2014 | US8637533 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 01/28/2014 | US8637532 Amino azaheterocyclic carboxamides |
| 01/28/2014 | US8637520 Substituted pyridyl amide compounds as modulators of the histamine H3 receptor |
| 01/28/2014 | US8637513 Heterocycle phenyl amide T-type calcium channel antagonists |
| 01/28/2014 | US8637500 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors |
| 01/28/2014 | US8637168 Materials for organic electroluminescence devices |
| 01/28/2014 | CA2621040C 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 01/28/2014 | CA2608929C Imidazolinone and hydantoine derivatives as novel inhibitors of histone deacetylase |
| 01/28/2014 | CA2560373C 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides |
| 01/28/2014 | CA2535265C Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 01/28/2014 | CA2508170C Pyrazine-based tubulin inhibitors |
| 01/23/2014 | WO2014015054A1 Beta amino acid derivatives as integrin antagonists |
| 01/23/2014 | WO2014014962A1 5ht3 receptor antagonists |
| 01/23/2014 | WO2014014951A1 5-ht3 receptor antagonists |
| 01/23/2014 | WO2014014874A1 Pyrazole derivatives which inhibit leukotriene production |
| 01/23/2014 | WO2014014310A1 A novel combination of a host compound and a dopant compound and an organic electroluminescence device comprising the same |
| 01/23/2014 | WO2014014270A1 Isoquinoline-5-carboxamide derivative having inhibitory activity for protein kinase |
| 01/23/2014 | WO2014014050A1 1-(cycloalkyl-carbonyl)proline derivative |
| 01/23/2014 | WO2014013469A1 Carbamate/urea derivatives |
| 01/23/2014 | WO2014013309A1 Indolecarbonitriles as selective androgen receptor modulators |
| 01/23/2014 | WO2014012934A1 Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof |
| 01/23/2014 | WO2014012880A1 Process for the preparation of intermediates for the synthesis of dabigatran etexilate, and crystalline forms of said intermediates |
| 01/23/2014 | WO2014012858A1 Pyridinone derivatives as tissue transglutaminase inhibitors |
| 01/23/2014 | WO2014012511A1 N-(3-heteroarylaryl)-4-arylarylcarboxamtdes and analogs as hedgehog pathway inhibitors and use thereof |
| 01/23/2014 | WO2014012401A1 Benzo-seven-member heterocyclic derivative and preparation method of benzo-seven-member heterocyclic derivative and medical application of benzo-seven-member heterocyclic derivative |
| 01/23/2014 | WO2014012236A1 Dabigatran etexilate derivative and preparation method and application thereof |
| 01/23/2014 | WO2013175494A3 Controlled release pharmaceutical formulations of direct thrombin inhibitors |
| 01/23/2014 | WO2013082345A8 Aryl dihydropyridinones and piperidinones as mgat2 inhibitors |
| 01/23/2014 | US20140024680 Insecticidal Arylpyrrolines |
| 01/23/2014 | US20140024665 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/23/2014 | US20140024650 Sulfonamide derivative and use thereof |
| 01/23/2014 | US20140024648 New pyridazinone and pyridone compounds |
| 01/23/2014 | US20140024647 Aromatic heterocyclic derivative having trpv4-inhibiting activity |
| 01/23/2014 | US20140024639 Compounds, Compositions, and Methods for Cancer Therapy |
| 01/23/2014 | US20140024620 Methods for Inhibiting Cell Proliferation in EGFR-Driven Cancers |
| 01/23/2014 | US20140023883 Carbazole end capped bipyridine compounds and process for preparation thereof |
| 01/23/2014 | US20140023642 1-(Arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP Inhibitors and the Use Thereof |
| 01/23/2014 | US20140023611 Compounds and methods for inhibiting phosphate transport |
| 01/22/2014 | EP2687523A1 Novel phenylpyridine derivative and drug containing same |
| 01/22/2014 | EP2687522A1 A polymorph of argatroban monohydrate and a process for its synthesis |
| 01/22/2014 | EP2687516A1 Inhibitors of C-FMS Kinase |
| 01/22/2014 | EP2687511A1 Pyridinone derivatives as tissue transglutaminase inhibitors |
| 01/22/2014 | EP2686317A2 Raf kinase inhibitors |
| 01/22/2014 | EP2686314A1 6,5-heterocyclic propargylic alcohol compounds and uses therefor |
| 01/22/2014 | EP2686313A1 Benz imidazole derivatives as inhibitors of glutaminyl cyclase |
| 01/22/2014 | EP2686312A1 N- cyclopropyl - n- piperidinylbenzamides as gpr119 modulators |
| 01/22/2014 | EP2686311A1 Fungicide hydroximoyl-tetrazole derivatives |
| 01/22/2014 | EP2686308A2 Antimicrobial agents |
| 01/22/2014 | EP2686303A1 N-(3-carbamoylphenyl)-1h-pyrazole-5-carboxamide derivatives and the use thereof for controlling animal pests |
| 01/22/2014 | EP2686302A1 Sulfonamide compounds having trpm8 antagonistic activity |
| 01/22/2014 | EP2686300A1 New azaspirodecanone compounds |
| 01/22/2014 | EP2685980A1 Methods and use of bifunctional enzyme-building clamp-shaped molecules |
| 01/22/2014 | EP2685828A1 Substituted 3-azabicyclo[3.1.0]hexane derivatives useful as ccr2 antagonists |
| 01/22/2014 | EP2685827A1 Pyrimidine cyclohexyl glucocorticoid receptor modulators |
| 01/22/2014 | CN103534832A Light-emitting element material and light-emitting element |
| 01/22/2014 | CN103534293A Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process |